FRENCH pharmaceutical giant Sanofi on Monday said it has yet to receive a formal document from the Department of Health (DoH) on the civil case it would file against the company regarding its refusal to refund used vials of anti-dengue vaccine Dengvaxia and indemnifying alleged victims of the drug.
"We have not received any formal document in relation to the civil case to be filed by the Department of Health in relation to the company’s response to the second request to refund the government for the used doses of Dengvaxia," the pharmaceutical firm said in a statement.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.